Back to Authors

Cao, Xiaofan

A5144250329 | I4210086996

Mayo Clinic

lBridgeBio Pharma, Inc., San Francisco, CA, US

Citations 1

Effect of acoramidis on risk of death and heart problem-related hospitalizations in people with transthyretin amyloid cardiomyopathy: a plain language summary

Future Cardiology | August 5, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-10

10.1080/14796678.2026.2702094 | PMID 42554365